Tag: Bayer
Shares crash: Does Bayer have to dismantle itself?
Things are getting tough for Bayer: the outlook is bleak, debts are high, and the pharmaceutical division is weakening. There are also legal hassles. The share price is plummeting. CEO…
Bayer wins furiously, RB fails: Unioners celebrate Urs Fischer and a small sense of achievement
Union Berlin is parting ways with coach Urs Fischer during the international break. In the first game after the exit, the fans thanked the Swiss with emotional messages. There is…
Bayer: fourth decline, towards a dark week for the title
(CercleFinance.com) – Bayer is lining up a fourth decline session this Thursday after a difficult start to the week, marked by renewed fears about the group’s pharmaceutical portfolio and the…
Bayer anticipates impacts on its cash flow after the clinical failure of its anticoagulant
Published on 11/21/2023 at 5:41 p.m. FRANKFURT, Nov 21 (Reuters) – Bayer’s strategic review will take into account a potentially tougher outlook for…
Bayer anticipates impacts on its cash flow after the clinical failure of its anticoagulant
Published on 11/21/2023 at 6:52 p.m. Photo credit © Reuters FRANKFURT (Reuters) – Bayer’s strategic review will…
Market: Bayer anticipates impacts on its cash flow after the clinical failure of its anticoagulant
FRANKFURT (Reuters) – Bayer’s strategic review will take into account a potentially tougher outlook for cash flow, its chief executive said on Tuesday, after abandoning a trial of the blood…
Bayer: up to -22% towards 32.6E
(CercleFinance.com) – Bayer is disintegrated by more than 20% following the accumulation of fines linked to the trials against its subsidiary Monsanto, but the blow of the day also comes…
Bayer unscrews after a dark weekend
(AOF) – Bayer (-18.24% to 33.86 euros) is bottom of the DAX40 after being hit by two bad news. On the one hand, the German chemical group announced on Sunday…
Bayer plunges on the stock market after throwing in the towel for its new anticoagulant
(BFM Bourse) – The German group plunges on the Frankfurt Stock Exchange, undermined by the cessation of its clinical trials relating to the development of a new anticoagulant, due to…
Market: Bayer falls after the clinical failure of its anticoagulant Asundexian
(Reuters) – Bayer fell on the stock market on Monday morning after announcing the day before the abandonment of a large phase III clinical trial involving a new anticoagulant drug,…
Bayer 04 Leverkusen against 1. FC Union Berlin on TV and live stream: This is how you see the Bundesliga game
BUNDESLIGA LIVE STREAM: WATCH FOOTBALL ON THE INTERNET November 12, 2023 at 11:30 a.m On Sunday afternoon, league leaders Bayer 04 Leverkusen will welcome 1. FC Union Berlin in the…
Bayer cancels study on hopeful Asundexian
Should reduce risk of stroke Bayer cancels study on hopefuls November 20, 2023, 7:39 a.m Listen to article This audio version was artificially generated. More info | Send feedback Taking…